March 20, 2020 / 4:15 PM / 13 days ago

Novartis to donate malaria drug in fight against coronavirus

ZURICH, March 20 (Reuters) - Novartis is donating up to 130 million doses of malaria drug hydroxychloroquine to be used in the fight against the new coronavirus, the Swiss company said on Friday.

There are no vaccines or treatments approved for the disease, but researchers are studying existing treatments including hydroxychloroquine for treating COVID-19.

Reporting by John Miller, Editing by Michael Shields

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below